NIPH Clinical Trials Search

A clinical study aiming to detect 17 types of cancer at an early stage through blood testing

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Breast, gastric, lung, prostate, colorectal and other cancers
Date of first enrollment	10/06/2024
Target sample size	3600
Countries of recruitment
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	Composition and expression levels of circulating microRNAs (miRNAs) in patients diagnosed with cancer and in individuals without cancer.
Secondary Outcome	Types and composition of miRNAs detectable by cancer type Quantitative values of tumor markers Age and sex of research participants Medical history and treatment history Cancer stage (TNM classification or equivalent)

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	1) Stage 0 or Stage I/II patients and, as a comparison, Stage III/IV patients. 2) Patients who have not received medical therapy against cancer cells such as chemotherapy or radiation therapy. The following patients will also be included for preoperative and postoperative comparisons 3) Patients who have received surgical or medical treatment. In addition, patients who have not been diagnosed with cancer by a physician shall be included. Translated with DeepL.com (free version)
Exclude criteria	1) Patients whose physician determines that there is a high probability of complications from bacterial infections. 2) Patients with an urgent and obvious life-threatening condition. 3) Other patients deemed inappropriate by the physician in charge of the study.